Advertisement

The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

What Is Selzentry

Here's a taste of what TheBody.com has to offer on this topic:
Get the Facts
Test Positive Aware Network

Selzentry

... Common Name: maraviroc (formerly UK-427,857) Brand Name: Selzentry Class: CCR5 antagonist (a type of entry inhibitor) Standard dose: without food, with no food restrictions. The recommended dose varies depending on other medications the patient is taking: 150 mg twice daily if taken
Ask the Experts

Question about Selzentry's side effects?

`My doctor wants to put me on Selzentry/Celsentri. He says that he has had very good immunological responses in his patients, compared with other drugs. Initially I would be on Truvada, Isentress, and Selzentry, but then after a few months of being...
Joseph McGowan, M.D., F.A.C.P.

Response from Joseph McGowan, M.D., F.A.C.P.

North Shore University Hospital
...Hello Thank you for your questions.The use of Selzentry (or Maraviroc) is a novel approach to treat HIV infection. There are ongoing discussions about using this drug as part of an Read more »

Fuzeon and Selzentry

Hello. I am in desperate need for your opinion. I tested HIV+ in 1990 when I had tonsilectomy and found KS in my tonsils. I have been on different therapies since 1996. I have become resistant to drugs in the three classes. My CD4 count has shown...
Benjamin Young, M.D., Ph.D.

Response from Benjamin Young, M.D., Ph.D.

Rocky Mountain CARES
...though with newer resistance tests (I use a genotype and phenotype in these circumstances) and newer medications, like maraviroc (Selzentry) or the yet-to-be approved raltegravir (Isentress), the options are much better. It's key that your... Read more »

side effects of crushing meds

I have written before and i thank you for the responses. I am starting a new regimen Truvada, Lexiva and Selzentry.I am trying to find out if crushing selzentry could be dangerous in any way. I have already crushed truvada for awhile and the lexiva...
Keith Henry, M.D.

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine
...I have seen no data (such as formal pharmacokinetic studies) on whether Selzentry (miraviroc) tablets can be crushed up. I am aware of several pxs who get their meds through feeding tubes which included maraviroc Read more »

What do you think about this combo?

I'm currently taking: Prezista, Norvir, Truvada & Intellence combo. How do you feel about this combo? I was also taking Selzentry but dropped it because of extreme joint pain.I look forward to your response.
Joseph McGowan, M.D., F.A.C.P.

Response from Joseph McGowan, M.D., F.A.C.P.

North Shore University Hospital
The combination that you have outlined was carefully studied in the DUET study and was found to potent in patients with underlying HIV drug resistance. So the regimen is certainly appropriate as long as your resistance test results indicate that... Read more »
Articles
The Body

Selzentry Labeling Includes New Warnings for People With Kidney Problems

... The CCR5 inhibitor Selzentry (Celsentri, maraviroc) should be used with caution by HIV-positive people with kidney problems, according to a U.S. Food and Read more »
U.S. Food and Drug Administration

Selzentry (Maraviroc) 150 mg and 300 mg Tablets, Labeling Changes for Patients With Renal Impairment

... On May 27, 2010, FDA approved changes to the labeling for Selzentry (maraviroc) 150 mg and 300 mg tablets to expand the patient population to include dosing recommendations for patients with renal Read more »
AIDSinfo

An Overview of Selzentry (Maraviroc, Celsentri)

... mah-RAV-er-rock Brand Name: Selzentry Other Name(s): Celsentri, MVC, UK-427,857 Drug Class: Entry and Fusion Inhibitors Maraviroc, also known as Selzentry, is Read more »
infoSIDA

Selzentry (Maraviroc)

... Brand Name: Selzentry Clase de medicamento: Inhibidor de la entrada y la fusión El maraviroc, también conocido como Selzentry, es un tipo de Read more »